Florida Cancer Specialists & Research Institute | Association Partnerships

Florida Cancer Specialists & Research Institute welcomes Board-certified medical oncologist/hematologist Madhu Unnikrishnan, MD.

Florida Cancer Specialists & Research Institute participated in the phase 3 POSEIDON, which led to FDA approval of a new immunotherapy that improves chemotherapy treatment for metastatic non small cell lung cancer.

Florida Cancer Specialists & Research Institute, welcomes Robert Ferdman, MD to the statewide practice.

Florida Cancer Specialists & Research Institute, LLC hematologists and medical oncologists were contributors to several presentations at the San Antonio Breast Cancer Symposium® this past week.

Research conducted at Florida Cancer Specialists & Research Institute that is contributing to global advancements in the diagnosis and treatment of blood diseases will be presented at ASH 2022.

Colorectal cancer screenings are effective at saving lives, according to Florida Cancer Specialists & Research Institute.

Florida Cancer Specialists & Research Institute, LLC recently celebrated its new clinical site location in Davenport, FL.

Diane Cope, PhD, APRN, BC, AOCNP evaluates the bone health of men with prostate cancer undergoing androgen deprivation therapy in a recently published manuscript, “Nursing Considerations for Androgen Deprivation Therapy and Bone Health in Men Affected by Prostate Cancer."

Florida Cancer Specialists & Research Institute welcomes Board-certified medical oncologist Ke Ning, MD to the Sarasota Downtown clinic team.

Real-world evidence from Florida Cancer Specialists & Research Institute shows that trilaciclib may reduce the chance of chemotherapy-induced myelosuppression events in patients with extensive-stage small cell lung cancer.

Michael Diaz, MD, will participate as a panelist for the Patient-Centered Oncology Care conference presented by The American Journal of Managed Care on November 9 – 10, 2022 in Nashville, TN.

Advanced treatments and technology for urologic disorders offered in one convenient location.

Florida Cancer Specialists & Research Institute, LLC has submitted an application to participate in Medicare’s Enhancing Oncology Care Model, an alternative payment model that aims to address healthcare inequities, reduce costs, and improve and report outcomes for cancer patients.

Physicians, clinicians and senior leaders of Florida Cancer Specialists & Research Institute, LLC will continue their long history of active involvement with the Florida Society of Clinical Oncology at the FLASCO Fall Session being held in Orlando, Oct. 28 & 29.

Florida Cancer Specialists & Research Institute has appointed Josh Eaves as Chief Development & Strategy Officer, reporting to Chief Executive Officer Nathan H. Walcker.

Michael Diaz, MD, will co-chair the Payer Exchange Summit on Oncology Payment Reform presented by the Community Oncology Alliance on October 24 and 25, 2022 in Tysons Corner, VA.

Florida Cancer Specialists & Research Institute locations in Palm Beach County are now offering Pluvicto, the first targeted radioligand therapy approved by the FDA to treat an advanced cancer called prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer.

Muhammad Imam, MD, reviews the use of newer antibody-drug conjugates for patients with metastatic breast cancer across subtypes.

Florida Cancer Specialists & Research Institute, LLC welcomes Monique Sajjad, DO.

Research conducted by Florida Cancer Specialists & Research Institute, LLC will be presented at the European Society of Medical Oncology Congress being held this week in Paris, France.

The “Every Step of the Way” campaign TV spot from Florida Cancer Specialists & Research Institute, LLC received a prestigious Platinum Hermes Award in the annual 2022 Hermes Creative Awards.

Florida Cancer Specialists & Research Institute celebrated the addition of genomic testing capabilities at its Next Generation Sequencing laboratory in Fort Myers last week with a ribbon cutting ceremony.

Florida Cancer Specialists & Research Institute welcomes Board-certified hematologist/oncologist Shivtaj Mann, DO to the statewide practice. He is providing care to patients at the FCS Fort Myers Cancer Center, 8260 Gladiolus Drive, Fort Myers, FL 33908.

Florida Cancer Specialists & Research Institute, LLC held a ribbon-cutting ceremony on August 18, 2022 to celebrate the opening of its newest clinical site in Pasco County.

Working collaboratively with Florida Cancer Specialists & Research Institute, LLC, NCODA, Inc. developed a more efficient way for healthcare professionals to expand their knowledge and share feedback about ongoing advancements.

Florida Cancer Specialists & Research Institute, LLC welcomes four Board-certified medical oncologists to the statewide practice, expanding care for patients receiving treatment for cancer and blood disorders. Joining FCS on August 1, 2022 are Mohammad Jahanzeb, MD, FACP, Tony J. Kurian, MD, Susan K. Morgan, MD and Wenqing Zhang, MD, PhD.

Mariuxi Viteri Malone, MD, has joined Florida Cancer Specialists & Research Institute.

Susanna Gaikazian, MD has joined Florida Cancer Specialists & Research Institute.

Nutrition as Prevention for Improved Cancer Health Outcomes is the focus of the three-day virtual gathering that will help identify priorities for research on nutritional interventions to prevent cancer-associated malnutrition and improve cancer health outcomes.

A refreshed platform serves as a critical foundation for the future of Florida Cancer Specialists.